Serum transferrin as a potential marker for prediction of prognosis for sudden sensorineural hearing loss: a prospective study.

IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY
Silin Zhang, Weiping Wang, Xiaowu Huang, Sa Chen, Danyi Du, Yu Chen, Xiangmin Zhang
{"title":"Serum transferrin as a potential marker for prediction of prognosis for sudden sensorineural hearing loss: a prospective study.","authors":"Silin Zhang, Weiping Wang, Xiaowu Huang, Sa Chen, Danyi Du, Yu Chen, Xiangmin Zhang","doi":"10.1186/s12883-025-04387-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Clinically significant prognostic indicators have not been identified for sudden sensorineural hearing loss (SSNHL). Consequently, this research aimed to evaluate the effectiveness of iron parameters in predicting prognostic outcomes for patients with SSNHL.</p><p><strong>Methods: </strong>Ninety-one individuals with SSNHL were prospectively enrolled and received steroid treatment at a dosage of 1 mg/kg/day for two weeks. Baseline characteristics and iron parameters were collected from participants. Afterward, the pre-and post-treatment hearing of the enrolled patients was compared. The effective group, defined as those with a pure tone audiometry (PTA) improvement of impaired frequencies of ≥ 15 dB or restoration to normal/ unaffected ear levels。.</p><p><strong>Results: </strong>In the entire cohort, the effective group exhibited a significantly younger age (p = 0.005) and baseline hearing level as well as transferrin saturation (p = 0.036) and higher transferrin levels (p = 0.002) in comparison to the ineffective group. Multivariate analysis identified age (OR, 0.931; 95% CI, 0.889-0.976; p = 0.003), the baseline hearing level (OR, 0.928; 95% CI, 0.894-0.964; p<0.001) and transferrin level (OR, 9.15; 95% CI, 1.838-45.555; p = 0.007) as independent predictors of treatment outcome.</p><p><strong>Conclusions: </strong>Higher transferrin levels were associated with an optimal outcome for SSNHL, however further research is needed to understand the mechanisms underlying this effect.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"25 1","pages":"367"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12395710/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12883-025-04387-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Clinically significant prognostic indicators have not been identified for sudden sensorineural hearing loss (SSNHL). Consequently, this research aimed to evaluate the effectiveness of iron parameters in predicting prognostic outcomes for patients with SSNHL.

Methods: Ninety-one individuals with SSNHL were prospectively enrolled and received steroid treatment at a dosage of 1 mg/kg/day for two weeks. Baseline characteristics and iron parameters were collected from participants. Afterward, the pre-and post-treatment hearing of the enrolled patients was compared. The effective group, defined as those with a pure tone audiometry (PTA) improvement of impaired frequencies of ≥ 15 dB or restoration to normal/ unaffected ear levels。.

Results: In the entire cohort, the effective group exhibited a significantly younger age (p = 0.005) and baseline hearing level as well as transferrin saturation (p = 0.036) and higher transferrin levels (p = 0.002) in comparison to the ineffective group. Multivariate analysis identified age (OR, 0.931; 95% CI, 0.889-0.976; p = 0.003), the baseline hearing level (OR, 0.928; 95% CI, 0.894-0.964; p<0.001) and transferrin level (OR, 9.15; 95% CI, 1.838-45.555; p = 0.007) as independent predictors of treatment outcome.

Conclusions: Higher transferrin levels were associated with an optimal outcome for SSNHL, however further research is needed to understand the mechanisms underlying this effect.

Abstract Image

Abstract Image

Abstract Image

血清转铁蛋白作为预测突发性感音神经性听力损失预后的潜在标志物:一项前瞻性研究。
目的:突发性感音神经性听力损失(SSNHL)的临床预后指标尚未确定。因此,本研究旨在评估铁参数在预测SSNHL患者预后结果中的有效性。方法:前瞻性纳入91例SSNHL患者,并接受剂量为1mg /kg/天的类固醇治疗,为期两周。收集参与者的基线特征和铁参数。之后,比较入组患者治疗前后的听力。有效组,定义为纯音听力(PTA)受损频率改善≥15 dB或恢复到正常/未受影响的耳朵水平。结果:在整个队列中,与无效组相比,有效组的年龄(p = 0.005)、基线听力水平、转铁蛋白饱和度(p = 0.036)和转铁蛋白水平(p = 0.002)明显更年轻。多因素分析确定年龄(OR, 0.931; 95% CI, 0.889-0.976; p = 0.003)、基线听力水平(OR, 0.928; 95% CI, 0.894-0.964)与SSNHL的最佳结局相关,但需要进一步研究以了解这种影响的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Neurology
BMC Neurology 医学-临床神经学
CiteScore
4.20
自引率
0.00%
发文量
428
审稿时长
3-8 weeks
期刊介绍: BMC Neurology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of neurological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信